n | % | |
Number of patients who received at least 1 injection with prefilled pen | 72 | 100 |
Injection site-related adverse event | ||
Injection site pain | 5 | 7 |
Injection site hematoma | 4 | 6 |
Injection site erythema | 2 | 3 |
Injection site hemorrhage | 2 | 3 |
Injection site induration | 2 | 3 |